Nanotracer Development to Track Stem Cell Therapy
追踪干细胞治疗的纳米示踪剂开发
基本信息
- 批准号:9922903
- 负责人:
- 金额:$ 41.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAutologousBiological ModelsBlood flowBone MarrowCardiovascular DiseasesCell Cycle KineticsCell DeathCell SurvivalCellsClinical TrialsDataData ReportingDetectionDevelopmentEventGastrocnemius MuscleGoalsGoldHindlimbHistologicHydrogelsHypoxiaImageImaging TechniquesImmune responseIn SituInductively Coupled Plasma Mass SpectrometryInfiltrationInflammatory InfiltrateInjectionsInjuryIschemiaLabelLeadLimb SalvageLimb structureLower ExtremityLysineMeasurementMeasuresMediatingMesenchymal Stem CellsMethodsModelingModificationMusMuscleMuscle CellsMuscle functionOpticsOutcomePatientsPeripheral arterial diseasePhenotypePhysiologicalPropertyRattusRecoveryRecovery of FunctionReperfusion TherapyResolutionRoleSafetySensitivity and SpecificityShapesSiteSystemTherapeuticTimeTissue imagingUltrasonographyVisualizationWorkabsorptionarginasebasebiomaterial compatibilitycellular imagingclinical developmentclinical efficacyclinically translatablecritical limb Ischemiaearly phase clinical trialhigh resolution imagingimaging studyimplantationimprovedimproved functioningin vivointerdisciplinary approachischemic injurymacrophagemouse modelnanoparticlenanoshellphotoacoustic imagingplasmonicspolyhexamethylene biguanidequantitative imagingrecruitregenerativerepairedresponsestem cell technologystem cell therapystem cellssurface coatingtherapy outcometissue regeneration
项目摘要
Project Summary
Peripheral artery disease (PAD) is a form of cardiovascular disease that can reduce blood flow in
the lower limbs ultimately resulting in the potential for loss of limb. Early clinical trials in patients with PAD
resulting in critical limb ischemia have demonstrated the safety of autologous stem cell therapies with
modest improvements in reperfusion and limb salvage. While stem cell therapies may therefore
represent a realistic alternative to conventional revascularization therapies, a number of challenges
remain which limit large-scale clinical trials and widespread use. Outcomes with respect to clinical
efficacy have been less than ideal and are largely attributed to the well-documented cell loss following
delivery. The overwhelming majority (>90 %) of cells do not survive implantation after 1-2 weeks.
We have described that a degradable hydrogel matrix can improve stem cell-mediated muscle
function recovery following ischemic injury. Our data suggested that one mechanism for improved
recovery was the increased number of cells that were maintained at the site of injury and their beneficial
effects on the host response. Central to our understanding is the necessity of being able to track stem
cells and the infiltrating inflammatory cells, particularly macrophages. Major challenges to the
development of clinically applied stem cell therapy remains the lack of technologies for stem cell tracking,
methods for the improvement of cell viability and strategies to understand the stem cell-mediated host
response. Therefore, the overall goal of the current proposal is to understand the role of delivered stem
cells and the mechanisms of repair in vivo using nanotracer-enhanced, high-resolution combined
ultrasound and photoacoustic (US/PA) imaging. A secondary goal is to be able to quantify the role of
recruited macrophages in a model system in which we are able to correlate imaging quantification with
quantitative measures of muscle function.
We propose here to utilize plasmonic gold nanoshells as nanotracers, due to their excellent
biocompatibility, as well as tunable, strong optical absorption properties. In contrast with other imaging
techniques, combined US/PA imaging can visualize and quantify cell delivery and function over a broad
range of timescales, spatial resolutions and imaging depths. High-resolution imaging of tissues is
possible as well as visualization in 3D. The combination of nanotracers with US/PA imaging results in a
unique approach that will allow us to answer fundamental questions regarding MSC involvement in
muscle repair as well as validate a clinically translatable solution for tissue regeneration. We propose to
develop this single system in a mouse model of hindlimb ischemia in which we are able to quantify
muscle function, thereby allowing correlation with tissue regeneration.
项目总结
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Assessing the range of enzymatic and oxidative tunability for biosensor design.
- DOI:10.1039/c9tb02666e
- 发表时间:2020-03
- 期刊:
- 影响因子:0
- 作者:H. Schunk;Derek S. Hernandez;M. J. Austin;Kabir S. Dhada;A. Rosales;L. Suggs
- 通讯作者:H. Schunk;Derek S. Hernandez;M. J. Austin;Kabir S. Dhada;A. Rosales;L. Suggs
A Dual Gold Nanoparticle System for Mesenchymal Stem Cell Tracking.
- DOI:10.1039/c4tb00975d
- 发表时间:2014-12-14
- 期刊:
- 影响因子:0
- 作者:Ricles LM;Nam SY;Treviño EA;Emelianov SY;Suggs LJ
- 通讯作者:Suggs LJ
Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration.
- DOI:10.1016/j.nantod.2012.10.007
- 发表时间:2012-12
- 期刊:
- 影响因子:17.4
- 作者:Chung E;Ricles LM;Stowers RS;Nam SY;Emelianov SY;Suggs LJ
- 通讯作者:Suggs LJ
Controlled release of IGF-I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion.
- DOI:10.1002/bit.24382
- 发表时间:2012-04
- 期刊:
- 影响因子:3.8
- 作者:Hammers DW;Sarathy A;Pham CB;Drinnan CT;Farrar RP;Suggs LJ
- 通讯作者:Suggs LJ
Fibrin-based 3D matrices induce angiogenic behavior of adipose-derived stem cells.
- DOI:10.1016/j.actbio.2015.01.012
- 发表时间:2015-04
- 期刊:
- 影响因子:9.7
- 作者:Chung, Eunna;Rytlewski, Julie A.;Merchant, Arjun G.;Dhada, Kabir S.;Lewis, Evan W.;Suggs, Laura J.
- 通讯作者:Suggs, Laura J.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura J Suggs其他文献
Laura J Suggs的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura J Suggs', 18)}}的其他基金
Development of Nanosensors to Image Macrophage Polarization
开发巨噬细胞偏振成像纳米传感器
- 批准号:
10460691 - 财政年份:2021
- 资助金额:
$ 41.84万 - 项目类别:
Nanotracer Development to Track Stem Cell Therapy
追踪干细胞治疗的纳米示踪剂开发
- 批准号:
8650826 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
Nanotracer Development to Track Stem Cell Therapy
追踪干细胞治疗的纳米示踪剂开发
- 批准号:
8276260 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
Nanotracer Development to Track Stem Cell Therapy
追踪干细胞治疗的纳米示踪剂开发
- 批准号:
9311528 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
Nanotracer Development to Track Stem Cell Therapy
追踪干细胞治疗的纳米示踪剂开发
- 批准号:
8463527 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
Development of Polydepsipeptides as Biomimetic Materials
聚缩酚肽仿生材料的开发
- 批准号:
8045890 - 财政年份:2011
- 资助金额:
$ 41.84万 - 项目类别:
Development of Polydepsipeptides as Biomimetic Materials
聚缩酚肽仿生材料的开发
- 批准号:
8213401 - 财政年份:2011
- 资助金额:
$ 41.84万 - 项目类别:
相似海外基金
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
- 批准号:
MR/Y019458/1 - 财政年份:2024
- 资助金额:
$ 41.84万 - 项目类别:
Research Grant
Fabrication and Evaluation of Poly(glycerol sebacate) based small diameter vascular graft as a potent substitution for autologous vessels
基于聚(甘油癸二酸酯)的小直径血管移植物作为自体血管有效替代品的制造和评估
- 批准号:
2897580 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Studentship
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head
自体骨髓抽吸浓缩液治疗股骨头坏死
- 批准号:
10658324 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
- 批准号:
10794761 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
SBIR Phase II: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts
SBIR II 期:可注射蛋白质基质,增强自体脂肪移植物的稳定性
- 批准号:
2304430 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Cooperative Agreement
Application of Autologous Connective Tissue Sheets Created in Patients' Bodies to Pediatric Cardiac Valvuloplasty and Development of Dedicated Molds
患者体内自体结缔组织片在小儿心脏瓣膜成形术中的应用及专用模具的开发
- 批准号:
23K15543 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
MICA: Strategy for heart repair in Duchenne Muscular Dystrophy (DMD) using genetically engineered autologous Mesoangioblasts
MICA:利用基因工程自体中成血管细胞修复杜氏肌营养不良症 (DMD) 的心脏的策略
- 批准号:
MR/X00466X/1 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Fellowship
Planning a phase I study of minor salivary gland derived autologous MSCs for prevention of long-term radiation induced xerostomia
计划对小唾液腺来源的自体 MSC 进行 I 期研究,以预防长期辐射引起的口干症
- 批准号:
10720234 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
SBIR 第二阶段,主题 429:自体和同种异体细胞治疗制造的新范式
- 批准号:
10976161 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation
自体干细胞移植后的 HIV 储库和基因修饰细胞动力学
- 批准号:
10700521 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别: